Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients

BACKGROUND: The prediction of therapy response in head and neck squamous cell cancer (HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy concepts. The current study aimed to identify therapy-responsive microRNAs (miRNAs) in the circulation that can serve as minimally...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Cancer
Prif Awduron: Summerer, I, Unger, K, Braselmann, H, Schuettrumpf, L, Maihoefer, C, Baumeister, P, Kirchner, T, Niyazi, M, Sage, E, Specht, H M, Multhoff, G, Moertl, S, Belka, C, Zitzelsberger, H
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2015
Pynciau:
Molecular Diagnostics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647540/
https://ncbi.nlm.nih.gov/pubmed/26057452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.111
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg